Bradley M. Halverson
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Constellation Energy Analyst Coverage Highlights AI Nuclear Debate. Recent news highlights analyst interest in Constellation Energy, with CIBC initiating coverage with an Outperformer rating and a $358 price target. This comes amid market debates over the company's role in powering AI data centers, following the CoreWeave partnership and the Brazos Valley sale. The stock trades with a P/E of 28.6 and a 0.91% yield as these strategic moves unfold.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Sysco Ends Strike, Morgan Stanley Raises Price Target. Sysco has reached an agreement with Teamsters locals to end its ongoing strike, resolving a key operational uncertainty. This development coincides with Morgan Stanley raising its price target to $91 while maintaining an Equal-Weight rating. Additionally, billionaire investor Dan Loeb’s Third Point has increased its stake in the company, signaling renewed institutional interest in the food distributor.
Transaction History
| LEA | ▲ Buy | Option Exercise | 1,859 | $0 | 5/14/2026 | View on chart |
| CEG | ▲ Buy | Grant | 556 | $170K | 4/28/2026 | View on chart |
| SYY | ▲ Buy | Grant | 2,797 | $0 | 11/14/2025 | View on chart |
| LEA | ▲ Buy | Option Exercise | 1,337 | $0 | 5/16/2025 | View on chart |
| CEG | ▲ Buy | Grant | 993 | $225K | 4/29/2025 | View on chart |
| CEG | ▲ Buy | Grant | 168 | $43K | 12/31/2024 | View on chart |
| SYY | ▲ Buy | Grant | 2,801 | $0 | 11/15/2024 | View on chart |
| CEG | ▲ Buy | Grant | 246 | $43K | 9/30/2024 | View on chart |
| CEG | ▲ Buy | Grant | 198 | $42K | 6/30/2024 | View on chart |
| LEA | ▲ Buy | Option Exercise | 1,419 | $0 | 5/16/2024 | View on chart |
| CEG | ▲ Buy | Grant | 247 | $43K | 3/31/2024 | View on chart |
| CEG | ▲ Buy | Grant | 349 | $42K | 12/31/2023 | View on chart |
| SYY | ▲ Buy | Grant | 2,900 | $0 | 11/17/2023 | View on chart |
| CEG | ▲ Buy | Grant | 391 | $42K | 9/30/2023 | View on chart |
| CEG | ▲ Buy | Grant | 456 | $43K | 6/30/2023 | View on chart |
| LEA | ▲ Buy | Option Exercise | 1,317 | $0 | 5/18/2023 | View on chart |
| CEG | ▲ Buy | Grant | 500 | $39K | 3/31/2023 | View on chart |
| CEG | ▲ Buy | Grant | 432 | $39K | 12/31/2022 | View on chart |
| SYY | ▲ Buy | Grant | 81 | $6K | 12/30/2022 | View on chart |
| SYY | ▲ Buy | Grant | 2,200 | $0 | 11/18/2022 | View on chart |
| CEG | ▲ Buy | Grant | 443 | $39K | 9/30/2022 | View on chart |
| SYY | ▲ Buy | Grant | 87 | $6K | 9/30/2022 | View on chart |
| CEG | ▲ Buy | Grant | 648 | $39K | 6/30/2022 | View on chart |
| SYY | ▲ Buy | Grant | 73 | $6K | 6/30/2022 | View on chart |
| LEA | ▲ Buy | Option Exercise | 875 | $0 | 5/19/2022 | View on chart |
| CEG | ▲ Buy | Grant | 495 | $25K | 3/31/2022 | View on chart |
| SYY | ▲ Buy | Grant | 75 | $6K | 3/31/2022 | View on chart |
| SYY | ▲ Buy | Grant | 80 | $6K | 12/30/2021 | View on chart |
| SYY | ▲ Buy | Grant | 2,469 | $0 | 11/19/2021 | View on chart |
| SYY | ▲ Buy | Grant | 77 | $6K | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
UBS and Goldman Sachs Lower Lear Price Targets
UBS and Goldman Sachs both maintained Neutral ratings on Lear but lowered their price targets to $132 and $124, respectively. This follows the stock trading near its support level, with the lower targets reflecting a more conservative outlook. The company remains in a list of attractive dividend stocks, maintaining a yield of 2.29%.
UBS and Goldman Sachs Lower Lear Price Targets. UBS and Goldman Sachs both maintained Neutral ratings on Lear but lowered their price targets to $132 and $124, respectively. This follows the stock trading near its support level, with the lower targets reflecting a more conservative outlook. The company remains in a list of attractive dividend stocks, maintaining a yield of 2.29%.